Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-26.55M
↓ 15% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-23.10M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-26.55M | +5.8% |
| 2024 | $-28.20M | +3.0% |
| 2023 | $-29.06M | -2.5% |
| 2022 | $-28.36M | +55.9% |
| 2021 | $-64.26M | -279.5% |
| 2020 | $-16.93M | -36.1% |
| 2019 | $-12.44M | -9.9% |
| 2018 | $-11.32M | -41.9% |
| 2017 | $-7.97M | -35.1% |
| 2016 | $-5.90M | - |